BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, February 8, 2026
Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

VBAS touted as a major change for neurosurgical retraction tech

March 26, 2010
By Omar Ford

Spirocor pulse oximeter test is effective in detecting CAD

March 25, 2010
By Omar Ford

Tiny ultrasound device could be novel therapy in treating arthritis

March 24, 2010
By Omar Ford
There are few treatment options for people who suffer from chronic pain or arthritis outside of pharmaceuticals, and those options can sometimes prove to be harmful if used for an extended period of time. But what if there was a better option with a significant amount of the side effects reduced? (Medical Device Daily)
Read More

Women survive heart attacks with more invasive therapies

March 22, 2010
By Omar Ford
ATLANTA — When it comes down to the rate at which men and women survive heart attacks and other cardio illnesses, there is a huge discrepancy between the two groups. A recent study shed more light on this discrepancy and revealed that women are more likely to survive a heart attack if they received the same level of therapy as males. (Medical Device Daily)
Read More

Genetic test gives greater insight into proper Warfarin dosage

March 19, 2010
By Omar Ford

Panel: Next Generation DES safer than previous iterations

March 18, 2010
By Omar Ford
ATLANTA — While the jury is still out on drug-eluting stents being safer and more effective than bare metal stents (Medical Device Daily, March 16, 2010), there is one question about the popular devices that can be conclusively answered. That is that the latest generation of DES seem to be much safer than their predecessors, according to a panel at the 59th Annual Scientific Session of the American College of Cardiology (ACC; Washington). (Medical Device Daily)
Read More

Bare-Metal stents better than DES? Research results mixed on answer

March 17, 2010
By Omar Ford

Healthcare reform debate still a key topic at ACC

March 16, 2010
By Omar Ford

From defensive program to tumors; Star Wars tech treats breast cancer

March 15, 2010
By Omar Ford

LenSx takes big steps toward femtosecond laser utilization

March 12, 2010
By Omar Ford
View All Articles by Omar Ford

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing